XML 99 R86.htm IDEA: XBRL DOCUMENT v3.21.1
SEGMENT AND ENTERPRISE-WIDE INFORMATION (Details)
$ in Thousands
 3 Months Ended 12 Months Ended
Apr. 03, 2021
USD ($)
Dec. 26, 2020
USD ($)
Sep. 26, 2020
USD ($)
Jun. 27, 2020
USD ($)
Mar. 28, 2020
USD ($)
Dec. 28, 2019
USD ($)
Sep. 28, 2019
USD ($)
Jun. 29, 2019
USD ($)
Apr. 03, 2021
USD ($)
unit
Mar. 28, 2020
USD ($)
Mar. 30, 2019
USD ($)
Segment Reporting Information [Line Items]                      
Number of business units | unit                 3    
Net revenues by business unit                 $ 851,310 $ 980,902 $ 953,159
Effect of exchange rates                 (1,605) (12,253) (5,486)
Net revenues $ 225,029 $ 240,371 $ 209,486 $ 195,577 $ 238,492 $ 258,970 $ 252,566 $ 238,451 870,463 988,479 967,579
Operating income (loss) (21,175) $ 40,425 $ 58,782 $ 11,715 26,007 $ 40,907 $ 49,739 $ (13,302) 89,747 103,351 83,545
Effect of exchange rates                 12,830 7,920 8,367
Restructuring Costs and Asset Impairment Charges                 (32,830) (25,746) (24,803)
Impairment of assets, PCS2 accelerated depreciation and other related charges                 25,696 75,750 40,296
Restructuring and Related Cost, Accelerated Depreciation                 18,421 568 0
Deal amortization                 (4,130) (1,506) 0
European Medical Device Regulation Costs                 897 (701) 2,726
Transaction and Integration costs                 32,812 8,083 0
Gains on divestitures and sale of assets                 (15,661) (19,878) (13,660)
Depreciation and amortization                 84,287 110,289 109,418
Total long-lived assets 217,559       253,399       217,559 253,399 343,979
Service [Member]                      
Segment Reporting Information [Line Items]                      
Net revenues                 20,758 19,830 19,906
Plasma products and services                      
Segment Reporting Information [Line Items]                      
Net revenues                 414,266 537,231 501,837
Blood Center products and services                      
Segment Reporting Information [Line Items]                      
Net revenues                 239,614 252,829 269,203
Hospital products and services                      
Segment Reporting Information [Line Items]                      
Net revenues                 216,583 198,419 196,539
United States                      
Segment Reporting Information [Line Items]                      
Net revenues                 522,607 646,204 606,845
Total long-lived assets 159,749       186,488       159,749 186,488 269,849
Japan                      
Segment Reporting Information [Line Items]                      
Net revenues                 77,676 72,218 69,908
Total long-lived assets 1,515       2,037       1,515 2,037 1,726
Europe                      
Segment Reporting Information [Line Items]                      
Net revenues                 159,077 153,347 164,504
Total long-lived assets 10,384       10,143       10,384 10,143 11,200
Asia                      
Segment Reporting Information [Line Items]                      
Net revenues                 105,820 109,295 118,700
Total long-lived assets 30,588       29,175       30,588 29,175 30,930
Other                      
Segment Reporting Information [Line Items]                      
Net revenues                 5,283 7,415 7,622
Total long-lived assets 15,323       25,556       15,323 25,556 30,274
North America Plasma                      
Segment Reporting Information [Line Items]                      
Depreciation and amortization                 20,522 8,513 9,623
Total long-lived assets 28,735       17,738       28,735 17,738 24,079
Hospital                      
Segment Reporting Information [Line Items]                      
Net revenues by business unit                 210,606 194,604 190,821
Plasma products and services                      
Segment Reporting Information [Line Items]                      
Net revenues by business unit                 333,334 460,637 426,781
Depreciation and amortization                 24,093 63,347 61,721
Total long-lived assets 105,599       141,903       105,599 141,903 192,628
Blood Center products and services                      
Segment Reporting Information [Line Items]                      
Net revenues by business unit                 307,370 325,661 335,557
Depreciation and amortization                 39,672 38,429 38,074
Total long-lived assets $ 83,225       $ 93,758       83,225 93,758 127,272
Operating Segments [Member]                      
Segment Reporting Information [Line Items]                      
Operating income (loss)                 398,491 465,822 420,266
Operating Segments [Member] | Hospital                      
Segment Reporting Information [Line Items]                      
Operating income (loss)                 84,066 80,669 76,338
Operating Segments [Member] | Plasma products and services                      
Segment Reporting Information [Line Items]                      
Operating income (loss)                 172,463 225,351 180,300
Operating Segments [Member] | Blood Center products and services                      
Segment Reporting Information [Line Items]                      
Operating income (loss)                 141,962 159,802 163,628
Corporate, Non-Segment [Member]                      
Segment Reporting Information [Line Items]                      
Corporate expenses (1)                 $ (256,751) $ (255,727) $ (263,603)